Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website http://www.gpo.gov/fdsys; (3) the federal government Internet portal USA.gov; or (4) a web search conducted using a commercial search engine such as http://www.google.com.
Accession Number PB2012-113988
Title Effect of GSTM1 Genotype on Ozone-Induced Allergic Airway Inflammation.
Publication Date Mar 2012
Media Count 46p
Personal Author H. Wong J. R. Balmes M. Arjomandi N. Holland
Abstract Epidemiological data suggest that persons with asthma may have greater morbidity as measured by health care utilization after O3 exposure than normal, healthy persons. Animal toxicological data provide evidence that O3 exposure can affect immune function, including enhancement of allergic inflammatory responses in the lungs. Previous controlled human exposure studies have confirmed that O3 exposure can enhance both the early and late bronchoconstrictor responses to inhaled antigen in allergic asthmatic subjects. The effects of O3 exposure on lower airway and late-phase inflammatory responses have not been adequately studied. Recently, data from both controlled human exposure and epidemiological studies have suggested that a common genetic polymorphism in an antioxidant enzyme, glutathione S-transferase m1 (GSTM1), is an important determinant of susceptibility to the respiratory effects of inhaled O3. We designed an experiment to determine whether persons with allergic asthma have increased susceptibility to O3 as a consequence of enhanced airway inflammatory responses to local endobronchial allergen challenge. This experiment was also designed to determine whether the effects of inhaled O3 on the specific airway inflammatory responses to allergen were enhanced in asthmatic individuals with the GSTM1 null genotype. The experiment used a repeated-measures design, each subject completing both O3 and filtered air (FA) exposures within the experiment, with the order of the exposures counter-balanced. Subjects were screened prior to beginning the experimental protocol so that 50% had the GSTM1 null genotype.
Keywords Air pollutants
Allergic diseases
Asthma
Drugs
Environmental exposure
Epidemiology
Genotypes
Glutathione S-transferase 51 (GSTM1)
Health care utilization
Humans
Immune response
Lungs
Ozone
Respiratory system disease

 
Source Agency California Air Resources Board Resources Agency
Environmental Protection Agency
NTIS Subject Category 57E - Clinical Medicine
57J - Immunology
68A - Air Pollution & Control
68G - Environmental Health & Safety
Corporate Author California State Univ., San Francisco. Human Exposure Laboratory.
Document Type Technical report
Title Note N/A
NTIS Issue Number 1225
Contract Number N/A

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader